Matches in Nanopublications for { ?s ?p "[A subset of gastric adenocarcinomas (71%) also showed reduced trypsinogen accompanied by reduction in PAR2, a G protein activated by trypsin, and a propensity to penetrate beyond the gastric wall (P = 0.001).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }
Showing items 1 to 12 of
12
with 100 items per page.
- NP932940.RAvEn7Ab_ffgAlhbNJauTqnbkTlSgTayrAp9XRt3luOTQ130_assertion description "[A subset of gastric adenocarcinomas (71%) also showed reduced trypsinogen accompanied by reduction in PAR2, a G protein activated by trypsin, and a propensity to penetrate beyond the gastric wall (P = 0.001).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP932940.RAvEn7Ab_ffgAlhbNJauTqnbkTlSgTayrAp9XRt3luOTQ130_provenance.
- NP374802.RAunp85N5OOMCswHsQNaNbzFk9fGmB6DNbePsfTIGQwqI130_assertion description "[A subset of gastric adenocarcinomas (71%) also showed reduced trypsinogen accompanied by reduction in PAR2, a G protein activated by trypsin, and a propensity to penetrate beyond the gastric wall (P = 0.001).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP374802.RAunp85N5OOMCswHsQNaNbzFk9fGmB6DNbePsfTIGQwqI130_provenance.
- assertion description "[A subset of gastric adenocarcinomas (71%) also showed reduced trypsinogen accompanied by reduction in PAR2, a G protein activated by trypsin, and a propensity to penetrate beyond the gastric wall (P = 0.001).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- NP390320.RAWGBrNaMwUCG-q2cHjZ5Eu_8hTcqGpc2UptzP3qsjPHI130_assertion description "[A subset of gastric adenocarcinomas (71%) also showed reduced trypsinogen accompanied by reduction in PAR2, a G protein activated by trypsin, and a propensity to penetrate beyond the gastric wall (P = 0.001).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP390320.RAWGBrNaMwUCG-q2cHjZ5Eu_8hTcqGpc2UptzP3qsjPHI130_provenance.
- NP761883.RA0ZqF-WNOex66HrG9F-H-o2wfIXY-soGH2AJqfDhXB6k130_assertion description "[A subset of gastric adenocarcinomas (71%) also showed reduced trypsinogen accompanied by reduction in PAR2, a G protein activated by trypsin, and a propensity to penetrate beyond the gastric wall (P = 0.001).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP761883.RA0ZqF-WNOex66HrG9F-H-o2wfIXY-soGH2AJqfDhXB6k130_provenance.
- NP808673.RAUiLeXt5tu0dN94oRlZrZx4FvhKq94cxL2m_lNf2JBUw130_assertion description "[A subset of gastric adenocarcinomas (71%) also showed reduced trypsinogen accompanied by reduction in PAR2, a G protein activated by trypsin, and a propensity to penetrate beyond the gastric wall (P = 0.001).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP808673.RAUiLeXt5tu0dN94oRlZrZx4FvhKq94cxL2m_lNf2JBUw130_provenance.
- assertion description "[A subset of gastric adenocarcinomas (71%) also showed reduced trypsinogen accompanied by reduction in PAR2, a G protein activated by trypsin, and a propensity to penetrate beyond the gastric wall (P = 0.001).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- assertion description "[A subset of gastric adenocarcinomas (71%) also showed reduced trypsinogen accompanied by reduction in PAR2, a G protein activated by trypsin, and a propensity to penetrate beyond the gastric wall (P = 0.001).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- NP418534.RASkF3FPgiA4KiV1itLXdKajqAuyao2M0HO2FEYnvdKXg130_assertion description "[A subset of gastric adenocarcinomas (71%) also showed reduced trypsinogen accompanied by reduction in PAR2, a G protein activated by trypsin, and a propensity to penetrate beyond the gastric wall (P = 0.001).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP418534.RASkF3FPgiA4KiV1itLXdKajqAuyao2M0HO2FEYnvdKXg130_provenance.
- NP418533.RAqrGTHxZllw5L-2J4fdgV8UOBX01n8Y-J_uquu7Ny5ps130_assertion description "[A subset of gastric adenocarcinomas (71%) also showed reduced trypsinogen accompanied by reduction in PAR2, a G protein activated by trypsin, and a propensity to penetrate beyond the gastric wall (P = 0.001).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP418533.RAqrGTHxZllw5L-2J4fdgV8UOBX01n8Y-J_uquu7Ny5ps130_provenance.
- NP916197.RAysjRDzTaUfqsWQDPEBU296GgEpo2ZLSSfargGmXitEA130_assertion description "[A subset of gastric adenocarcinomas (71%) also showed reduced trypsinogen accompanied by reduction in PAR2, a G protein activated by trypsin, and a propensity to penetrate beyond the gastric wall (P = 0.001).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP916197.RAysjRDzTaUfqsWQDPEBU296GgEpo2ZLSSfargGmXitEA130_provenance.
- NP418532.RAyPl8ZdhhuLGBGZk8hLagIM_wzXNfzFFGJmh-CaiwJnE130_assertion description "[A subset of gastric adenocarcinomas (71%) also showed reduced trypsinogen accompanied by reduction in PAR2, a G protein activated by trypsin, and a propensity to penetrate beyond the gastric wall (P = 0.001).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP418532.RAyPl8ZdhhuLGBGZk8hLagIM_wzXNfzFFGJmh-CaiwJnE130_provenance.